During the past decade, Klinikum Sindelfingen-Böblingen conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Sindelfingen-Böblingen" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Ipsen" with 1 trials sponsored, "Technical University of Munich" with 1 trials sponsored, "Technische Universität Dresden" with 1 trials sponsored and "University of Ulm" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Sindelfingen-Böblingen" #1 collaborator was "Masaryk University" with 1 trials as a collaborator and "Universitätsklinikum Dresden, Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Sindelfingen-Böblingen" are "Migraine" (2 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Leukemia, Myelocytic, Acute" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Klinikum Sindelfingen-Böblingen" in a lesser frequency.

Most popular intervention types in "Klinikum Sindelfingen-Böblingen" are "Drug" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lasmiditan" (2 trials), "Cytarabine" (1 trials), "Dasatinib" (1 trials), "Pazopanib+Sorafenib" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Sindelfingen-Böblingen" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Sindelfingen-Böblingen". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinikum Sindelfingen-Böblingen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Sindelfingen-Böblingen, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".